[HTML][HTML] Biomaterial-based activation and expansion of tumor-specific T cells
Traditional tumor vaccination approaches mostly focus on activating dendritic cells (DCs) by
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
[HTML][HTML] Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells
M Schluck, R Hammink, CG Figdor, M Verdoes… - Frontiers in …, 2019 - frontiersin.org
Traditional tumor vaccination approaches mostly focus on activating dendritic cells (DCs) by
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells.
M Schluck, R Hammink, CG Figdor… - Frontiers in …, 2019 - europepmc.org
Traditional tumor vaccination approaches mostly focus on activating dendritic cells (DCs) by
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
[PDF][PDF] Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells
M Schluck, R Hammink, CG Figdor, M Verdoes… - 2019 - repository.ubn.ru.nl
Traditional tumor vaccination approaches mostly focus on activating dendritic cells (DCs) by
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
[HTML][HTML] Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells
M Schluck, R Hammink, CG Figdor… - Frontiers in …, 2019 - ncbi.nlm.nih.gov
Traditional tumor vaccination approaches mostly focus on activating dendritic cells (DCs) by
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells
M Schluck, R Hammink, CG Figdor… - Frontiers in …, 2019 - pubmed.ncbi.nlm.nih.gov
Traditional tumor vaccination approaches mostly focus on activating dendritic cells (DCs) by
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
[PDF][PDF] Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells
M Schluck, R Hammink, CG Figdor, M Verdoes… - core.ac.uk
Traditional tumor vaccination approaches mostly focus on activating dendritic cells (DCs) by
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells
M Schluck, R Hammink, CG Figdor… - Novel Strategies of …, 2020 - books.google.com
Traditional tumor vaccination approaches mostly focus on activating dendritic cells (DCs) by
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells.
M Schluck, R Hammink, CG Figdor… - Frontiers in …, 2019 - europepmc.org
Traditional tumor vaccination approaches mostly focus on activating dendritic cells (DCs) by
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
[PDF][PDF] Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells
M Schluck, R Hammink, CG Figdor, M Verdoes… - core.ac.uk
Traditional tumor vaccination approaches mostly focus on activating dendritic cells (DCs) by
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …
providing them with a source of tumor antigens and/or adjuvants, which in turn activate …